跳至主要内容
临床试验/RPCEC00000329
RPCEC00000329已完成未知

A study to observe patients characteristics, treatment patterns and outcomes in patients with newly diagnosed breast cancer in Latin America. - LatinaBreast

Roche Servicios S.A.0 个研究点开始时间: 2020年8月6日最近更新:
适应症

试验速览

阶段
未知
状态
已完成

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 years 至 one(—)
性别
All

入选标准

  • Histological confirmed newly diagnosed stage I to IV (recurrent or de novo) breast cancer no more than 12 months prior to site activation, although they can have received anti-cancer treatment during that time

排除标准

  • 1. Patients not receiving treatment for breast cancer with national approved drugs according to standard of care and in line with the current summary of product characteristics (SPC) /local labeling
  • 2. Patients not receiving the Roche studied medicinal product, but a biosimilar

研究者

相似试验

A Study to Describe the Diagnosis, Anti-Cancer... | 临床试验